Gastric Cancer Pipeline Review H1 2017 Research Report Now Available at Orbis Research

1
Gastric Cancer-Pipeline Review, H1 2017
2
Gastric Cancer-Pipeline Review, H1 2017

• Gastric Cancer - Pipeline Review, H1
  2017, provides comprehensive information on the
  therapeutics under development for Gastric Cancer
  (Oncology), complete with analysis by stage of
  development, drug target, mechanism of action
  (MoA), route of administration (RoA) and molecule
  type. The guide covers the descriptive
  pharmacological action of the therapeutics, its
  complete research and development history and
  latest news and press releases.
• Request a sample of this report _at_
  http//www.orbisresearch.com/contacts/request-samp
  le/289277 .
• Gastric cancer, also called stomach
  cancer, is a malignant tumor arising from the
  lining of the stomach. Signs and symptoms of
  gastric cancer include fatigue, stomach pain,
  vomiting, weight loss that is unintentional,
  feeling bloated after eating, heartburn and
  indigestion. Risk factors include smoking,
  pernicious anemia, stomach polyps, infection with
  helicobacter pylori and family history of stomach
  cancer. Treatment includes surgery, chemotherapy
  and radiation therapy.

3
Gastric Cancer-Pipeline Review, H1 2017

• About Us
• Orbis Research (orbisresearch.com) is a
  single point aid for all your market research
  requirements. We have vast database of reports
  from the leading publishers and authors accross
  the globe. We specialize in delivering customised
  reports as per the requirements of our clients.
  We have complete information about our publishers
  and hence are sure about the accuracy of the
  industries and verticals of their specialisation.
  This helps our clients to map their needs and we
  produce the perfect required market research
  study for our clients.
• Contact Information
• 4144N Central Expressway,
• Suite 600, Dallas,
• Texas - 75204, U.S.A.
• Phone No. 1 [phone]
• enquiry_at_orbisresearch.com
• sales_at_orbisresearch.com